Epicardial Adipose Tissue Composition and Heart Failure With Preserved Ejection Fraction
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 192 participants.
Also called NCT07178145
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose diagnostic
- Phase
- Phase 4
- Enrolled
- 192 participants
- Registry
-
NCT07178145
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT07178145. Non-randomized; no masking; primary purpose diagnostic. Start 2025-11-20 (actual); primary completion 2029-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Epicardial Adipose Tissue Composition and Heart Failure With Preserved Ejection Fraction
- Condition
- Heart Failure Preserved Ejection Fraction
- Condition
- Epicardial Adipose Tissue
- Intervention (Drug)
- GLP-1RA
- Lead sponsor
- University of Virginia
- Collaborator
- National Institutes of Health (NIH)
Record details
- Record id
cardio:ct-nct07178145- Content hash
a5330d1add4928677c69fced27870c88fdf1fa1fcca21c2d2f1889610ca527ab